Literature DB >> 3619193

Determination of minimal inhibitory concentrations of antituberculosis drugs by radiometric and conventional methods.

C N Lee, L B Heifets.   

Abstract

Minimal inhibitory Concentrations (MIC) of 5 antituberculosis drugs (isoniazid, rifampin, streptomycin, ethionamide, and ethambutol) were determined by the radiometric (BACTEC) broth method and by the agar plate proportion method. Seventeen M. tuberculosis strains, isolated from patients before treatment, were tested. The MIC values of 4 of the 5 drugs (the exception was streptomycin) were 2 to 4 times lower in 7H12 broth than in 7H11 agar. The broth-determined MIC were also at least 2 to 4 times lower than the achievable serum concentrations. The broth-determined MIC are probably much closer to the true MIC values than those determined in agar plates because of the lower degree of absorption and degradation in the liquid medium. The radiometric broth method is a simple and rapid quantitative method for accurate determination of the MIC values of the antituberculosis drugs. The data obtained in this study will be used for further evaluation of the MIC values as complementary or alternative to the conventional qualitative testing against critical concentrations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3619193     DOI: 10.1164/ajrccm/136.2.349

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  35 in total

1.  Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.

Authors:  G E Pfyffer; D A Bonato; A Ebrahimzadeh; W Gross; J Hotaling; J Kornblum; A Laszlo; G Roberts; M Salfinger; F Wittwer; S Siddiqi
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

Review 2.  Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.

Authors:  W J Burman; K Gallicano; C Peloquin
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

3.  Evaluation of mycobacteria growth indicator tube for recovery and drug susceptibility testing of Mycobacterium tuberculosis isolates from respiratory specimens.

Authors:  M Palaci; S Y Ueki; D N Sato; M A Da Silva Telles; M Curcio; E A Silva
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

4.  Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.

Authors:  Manzour Hernando Hazbón; Michael Brimacombe; Miriam Bobadilla del Valle; Magali Cavatore; Marta Inírida Guerrero; Mandira Varma-Basil; Helen Billman-Jacobe; Caroline Lavender; Janet Fyfe; Lourdes García-García; Clara Inés León; Mridula Bose; Fernando Chaves; Megan Murray; Kathleen D Eisenach; José Sifuentes-Osornio; M Donald Cave; Alfredo Ponce de León; David Alland
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

5.  Bactericidal activities of the pyrrole derivative BM212 against multidrug-resistant and intramacrophagic Mycobacterium tuberculosis strains.

Authors:  D Deidda; G Lampis; R Fioravanti; M Biava; G C Porretta; S Zanetti; R Pompei
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

Review 6.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

7.  Effect of sex and AIDS status on the plasma and intrapulmonary pharmacokinetics of rifampicin.

Authors:  John E Conte; Jeffrey A Golden; Juliana E Kipps; Emil T Lin; Elisabeth Zurlinden
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  Safe determination of susceptibility of Mycobacterium tuberculosis to antimycobacterial agents by flow cytometry.

Authors:  A V Moore; S M Kirk; S M Callister; G H Mazurek; R F Schell
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry.

Authors:  M A Norden; T A Kurzynski; S E Bownds; S M Callister; R F Schell
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

10.  Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours.

Authors:  S M Kirk; R F Schell; A V Moore; S M Callister; G H Mazurek
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.